The relationship between tumour dosimetry, response, and overall survival in patients with unresectable Neuroendocrine Neoplasms (NEN) treated with (177)Lu DOTATATE (LuTate)

ABSTRACT: Peptide Receptor Radionuclide Therapy (PRRT) delivers targeted radiation to Somatostatin Receptor (SSR) expressing Neuroendocrine Neoplasms (NEN). We sought to assess the predictive and prognostic implications of tumour dosimetry with respect to response by (68) Ga DOTATATE (GaTate) PET/CT...

Descripción completa

Detalles Bibliográficos
Autores principales: Alipour, R., Jackson, P., Bressel, M., Hogg, A., Callahan, J., Hicks, R. J., Kong, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382388/
https://www.ncbi.nlm.nih.gov/pubmed/37184682
http://dx.doi.org/10.1007/s00259-023-06257-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382388/
https://www.ncbi.nlm.nih.gov/pubmed/37184682
http://dx.doi.org/10.1007/s00259-023-06257-6

Ejemplares similares